Search

everythinglearnresearchcommunity

for

Search:↓

Belimumab effectively reduces disease activity in lupus patients, regardless of initial serologic status.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Diagnosing new systemic lupus during pregnancy is hard but important for the health of the mother and baby.

Following national healthy eating guidelines can help reduce risks from gender-affirming hormone therapy.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Fibromyalgia slightly more common in SLE patients but doesn't affect SLE activity assessments.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

New treatments for lupus show promise, but more research is needed, especially for children.

SLE patients experience two patterns of non-inflammatory symptoms: intermittent and persistent.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Early detection and infection prevention are crucial for improving survival in pediatric lupus patients with aplastic anemia.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Living with lupus as both a patient and doctor improved understanding and care for others.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

A fungus ball in the lung can cause coughing up blood in SLE patients.